NCT04458194

Brief Summary

This feasibility phase II randomized controlled trial examines the preliminary efficacy of our standardized four-week YOCAS©® (Yoga for Cancer Survivors) intervention that is delivered virtually on insomnia and sleep quality in cancer survivors. Insomnia can be described as excessive daytime napping, difficulty falling asleep, difficulty staying asleep, or waking up earlier than desired. The vast majority of patients with cancer experience some form of sleep impairment post-treatment. Yoga is safe, feasible, and effective for improving insomnia and sleep quality in cancer survivors. However, most of the yoga intervention was delivered in person. With the challenges and the social distancing regulation regarding the COVID-19 pandemic, adapting to virtual behavioral intervention is critically important and needed. Whether the yoga intervention delivered virtually to survivors provides a similar benefit of improving insomnia and sleep quality is unknown.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started Jan 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Jan 2022Nov 2026

First Submitted

Initial submission to the registry

June 30, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 7, 2020

Completed
1.5 years until next milestone

Study Start

First participant enrolled

January 12, 2022

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Expected
Last Updated

April 16, 2026

Status Verified

April 1, 2026

Enrollment Period

3.9 years

First QC Date

June 30, 2020

Last Update Submit

April 14, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean change in insomnia as measured by the Insomnia Severity Index (ISI) total score comparing cancer survivors in YOCAS vs. Standard Care

    The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change among cancer survivors in YOCAS vs. Standard Care

    baseline to week 5

Secondary Outcomes (1)

  • Mean Change in sleep quality as measured by the Pittsburgh Sleep Quality Inventory (PSQI) total Score comparing cancer survivors in YOCAS vs. Standard Care

    baseline to week 5

Study Arms (2)

Standard Care

ACTIVE COMPARATOR

Cancer survivors receive their standard care

Other: Standard Care

YOCAS

EXPERIMENTAL

Cancer survivors receive 8 virtual yoga sessions (75 minutes/session, 2 times a week for 4 weeks) delivered via an electronic platform (e.g., Zoom)

Behavioral: YOCAS©® yoga

Interventions

Standard Care is used as a control condition. Cancer survivors assigned to this arm continue to receive standard care from their medical providers.

Standard Care
YOCAS©® yogaBEHAVIORAL

Yoga for Cancer Survivors, YOCAS©®, intervention is a low to moderate intensity mode of exercise that draws from two basic types of yoga; gentle Hatha and Restorative yoga. The program includes specific physical postures and mindfulness exercises focused on breathing and meditation. Cancer survivors will participate in 8 virtual YOCAS sessions (75 minutes/session, 2 times a week for 4 weeks) delivered via an electronic platform (e.g., Zoom)

YOCAS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cancer Survivors must:
  • have a confirmed diagnosis of cancer
  • have received surgery, chemotherapy, and/or radiation therapy
  • have completed all surgery, chemotherapy, and/or radiation therapy within the last 2 months to 10 years
  • score ≥4 on a 0-10 sleep screening scale
  • be at least 18 years of age
  • be able to read and understand English
  • be able to provide informed consent
  • have access to the internet and a smartphone, tablet, and/or computer
  • have the ability to attend 8 virtual yoga sessions

You may not qualify if:

  • Cancer Survivor must not:
  • have contraindications to yoga participation
  • have practiced yoga within the 3 months prior to enrolling in the study
  • be planning to start yoga on their own during the time they are enrolled in the study
  • have a confirmed diagnosis of sleep apnea or restless leg syndrome
  • be receiving any form of treatment for cancer with the exception of hormonal or biologic therapy
  • have distant metastases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Bassett Research Institute

Cooperstown, New York, 13326, United States

Location

University of Rochester Medical Center

Rochester, New York, 14642, United States

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Karen Mustian, PhD, MPH

    University of Rochester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 30, 2020

First Posted

July 7, 2020

Study Start

January 12, 2022

Primary Completion

November 30, 2025

Study Completion (Estimated)

November 30, 2026

Last Updated

April 16, 2026

Record last verified: 2026-04

Locations